MannKind Corporation Common Stock MNKD
i
Market dataready · fetched 2026-11-10T22:24:39.643Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:00:02.287941729Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-10T22:24:39.218880+00:00
MannKind Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | 4.21 | 74.9% | 3.4% | |||
| 65Δ | 4.17 | 72.2% | 2.8% | |||
| 70Δ | 4.12 | 69.5% | 2.2% | |||
| 75Δ | 4.08 | 66.8% | 1.7% | |||
| 80Δ | 4.04 | 64.1% | 1.1% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 4.21
- IV
- 74.9%
- B/E move
- 3.4%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 4.17
- IV
- 72.2%
- B/E move
- 2.8%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 4.12
- IV
- 69.5%
- B/E move
- 2.2%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 4.08
- IV
- 66.8%
- B/E move
- 1.7%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 4.04
- IV
- 64.1%
- B/E move
- 1.1%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 294.33% | |
| 348.43% | |
| 270.29% | |
| 304.12% | |
| 381.39% | |
| 496.30% | |
| 284.90% | |
| 130.27% | |
| 252.04% | |
| 273.23% | |
| 328.07% | |
| 85.91% | |
| 326.20% | |
| 309.19% | |
| 243.59% | |
| 437.34% | |
| 317.58% | |
| 188.92% | |
| 236.21% | |
| 345.93% | |
| 317.92% | |
| 260.20% | |
| 311.18% | |
| 202.41% | |
| 376.52% | |
| 325.93% | |
| 182.48% | |
| 449.29% | |
| 412.03% | |
| 300.99% | |
| 485.50% | |
| 485.03% | |
| 437.41% | |
| 350.42% | |
| 327.46% | |
| 198.83% | |
| 186.90% |
Biotechnology
MPLT
MapLight Therapeutics, Inc. is an innovative biotechnology company that is dedicated to developing groundbreaking therapies for complex neurological and psychiatric disorders.…
More →MRNA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases,…
More →MRVI
Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines, and to support human…
More →NAMS
NewAmsterdam Pharma Company N.V. is a forward-looking biotechnology firm focused on the development of innovative therapies for cardiometabolic diseases, leveraging its…
More →NAUT
Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is…
More →NBTX
Nanobiotix SA, a clinical-stage biotechnology, is focused on the development of candidate products for the treatment of cancer. The company is headquartered in Paris, France.
More →